Randomized Safety Study of CVT-301 Compared to an Observational Control Group
Thématique(s) / pathologie(s)
- Maladie de Parkinson
Objectifs
Plus d'informations disponibles sur : https://clinicaltrials.gov/ct2/show/record/NCT02352363?term=CVT-301-005&rank=1
Promoteur
Acorda Therapeutics
Publication(s) scientifique(s)
-
Grosset DG et al. Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. Parkinsonism Relat Disord. 2020 Feb;71:4-10.
Statut
Résultats publiés